SOMATULINE AUTOGEL Solution for injection Ref.[8589] Active ingredients: Lanreotide

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2022  Publisher: Ipsen Limited, 190 Bath Road, Slough, Berkshire, SL1 3XE, UK

Product name and form

Somatuline Autogel 60 mg, solution for injection in a pre-filled syringe.

Somatuline Autogel 90 mg, solution for injection in a pre-filled syringe.

Somatuline Autogel 120 mg, solution for injection in a pre-filled syringe.

Pharmaceutical Form

Solution for injection in a pre-filled syringe.

White to pale yellow semi-solid formulation.

Qualitative and quantitative composition

Lanreotide (I.N.N.), 60 mg, 90 mg or 120 mg (as acetate).

Each pre-filled syringe contains a supersaturated solution of lanreotide acetate corresponding to 0.246 mg lanreotide base/mg of solution, which ensures an actual injection dose of 60 mg, 90 mg or 120 mg of lanreotide, respectively.

For excipients, see 6.1.

Active Ingredient Description
Lanreotide

Lanreotide is an octapeptide analogue of natural somatostatin. Like somatostatin, lanreotide is an inhibitor of various endocrine, neuroendocrine, exocrine and paracrine functions.

List of Excipients

Water for injection
Glacial acetic acid (for pH adjustment)

Pack sizes and marketing

Somatuline Autogel is supplied in a pre-filled syringe (polypropylene) fitted with an automatic safety system with a plunger stopper (bromobutyl rubber) and a needle (stainless steel) covered by a plastic cap.

Each ready to use pre-filled syringe is placed into a plastic tray and packed in a laminated pouch and a cardboard box.

Box of one 0.5 ml pre-filled syringe with one needle (1.2 mm x 20 mm).

Marketing authorization holder

Ipsen Limited, 190 Bath Road, Slough, Berkshire, SL1 3XE, UK

Marketing authorization dates and numbers

PL 34926/0005 (Somatuline Autogel 60 mg)
PL 34926/0006 (Somatuline Autogel 90 mg)
PL 34926/0007 (Somatuline Autogel 120 mg)

Date of first authorisation: 16 October 2001
Date of latest renewal: 07 April 2009

Drugs

Drug Countries
SOMATULINE Austria, Australia, Brazil, Canada, Cyprus, Estonia, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.